The Japan Fair Trade Commission paid a surcharge of greater than 620 million yen to 5 pharmaceutical wholesalers for repeated collusion over bidding for prescribed drugs within the Kyushu area ordered by the unbiased administrative company “National Hospital Organization”. ordered to
was ordered to pay the advantageous for
â—† Under the umbrella of a significant pharmaceutical wholesaler
â–½ “Shoyaku”
â–½ “Kyushu Toho”
â–½In addition to Alfresa,
â—† Pharmaceutical wholesale
â–½ “Astem” in Oita City
â–½The 5 corporations of “Tomita Pharmaceutical” in Kumamoto City.
The Fair Trade Commission proceeded with the investigation by conducting an on-site inspection the yr earlier than, and introduced the outcomes on the twenty fourth.
According to the report, the 5 corporations have been holding discussions since June 2016 on the newest to resolve which firm will win the joint bid for prescribed drugs ordered by the National Hospital Organization for 31 hospitals in Kyushu. That’s it.
In the three and a half years by which rigging was acknowledged, orders totaled 25,000 objects price roughly 85 billion yen.
The Japan Fair Trade Commission ordered 5 corporations to pay a surcharge totaling greater than 620 million yen, and issued a stop and desist order to stop recurrence.
On the opposite hand, Atoll, which is beneath the umbrella of a significant pharmaceutical wholesaler, voluntarily declared the violation earlier than the on-site inspection was performed, so it was exempted from the surcharge and didn’t obtain a stop and desist order.